| Dr Andrew James Mostello, DO | |
|
352 S Delsea Dr Unit C, Vineland, NJ 08360-5308 | |
| (856) 690-1616 | |
| (856) 896-6107 |
| Full Name | Dr Andrew James Mostello |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 352 S Delsea Dr Unit C, Vineland, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124454822 | NPI | - | NPPES |
| 1124454822 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 289253 (Massachusetts) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 25MB10574200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Inspira Medical Center Elmer | Elmer, NJ | Hospital |
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Heywood Hospital - | Gardner, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Orthopaedic And Sports Medicine Assoc Of Southern Nj Llc | 1557388436 | 37 |
| Longview Orthopaedic Center, Llc | 8628143120 | 6 |
News Archive
What's clear is that committee Democrats moved awfully far in the name of compromise. They offered more in Medicare cuts than Simpson-Bowles did -; or than Obama did with Boehner, for that matter -; and accepted less in the way of tax increases than those two proposals. For their part, Republicans moved off their position of complete intransigence on taxes. Then they refused to budge.
Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.
ReBuilder Medical Technologies, Inc. has announced that it has negotiated an exclusive license from White Hall, Inc. for the micronized, amorphous silver ion technology to treat the highly contagious skin disease, Molluscum Contagiosum.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
Treatment with the novel neuroprotective agent NA-1 reduces the number of ischemic infarcts sustained by patients undergoing coiling of cerebral aneurysms, show the ENACT results.
› Verified 6 days ago
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164432761 PECOS PAC ID: 9830003417 Enrollment ID: O20040207000017 |
News Archive
What's clear is that committee Democrats moved awfully far in the name of compromise. They offered more in Medicare cuts than Simpson-Bowles did -; or than Obama did with Boehner, for that matter -; and accepted less in the way of tax increases than those two proposals. For their part, Republicans moved off their position of complete intransigence on taxes. Then they refused to budge.
Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.
ReBuilder Medical Technologies, Inc. has announced that it has negotiated an exclusive license from White Hall, Inc. for the micronized, amorphous silver ion technology to treat the highly contagious skin disease, Molluscum Contagiosum.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
Treatment with the novel neuroprotective agent NA-1 reduces the number of ischemic infarcts sustained by patients undergoing coiling of cerebral aneurysms, show the ENACT results.
› Verified 6 days ago
| Entity Name | Premier Orthopaedic And Sports Medicine Assoc Of Southern Nj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396812574 PECOS PAC ID: 1557388436 Enrollment ID: O20051031000150 |
News Archive
What's clear is that committee Democrats moved awfully far in the name of compromise. They offered more in Medicare cuts than Simpson-Bowles did -; or than Obama did with Boehner, for that matter -; and accepted less in the way of tax increases than those two proposals. For their part, Republicans moved off their position of complete intransigence on taxes. Then they refused to budge.
Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.
ReBuilder Medical Technologies, Inc. has announced that it has negotiated an exclusive license from White Hall, Inc. for the micronized, amorphous silver ion technology to treat the highly contagious skin disease, Molluscum Contagiosum.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
Treatment with the novel neuroprotective agent NA-1 reduces the number of ischemic infarcts sustained by patients undergoing coiling of cerebral aneurysms, show the ENACT results.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew James Mostello, DO 352 S Delsea Dr Unit C, Vineland, NJ 08360-5308 Ph: (856) 690-1616 | Dr Andrew James Mostello, DO 352 S Delsea Dr Unit C, Vineland, NJ 08360-5308 Ph: (856) 690-1616 |
News Archive
What's clear is that committee Democrats moved awfully far in the name of compromise. They offered more in Medicare cuts than Simpson-Bowles did -; or than Obama did with Boehner, for that matter -; and accepted less in the way of tax increases than those two proposals. For their part, Republicans moved off their position of complete intransigence on taxes. Then they refused to budge.
Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.
ReBuilder Medical Technologies, Inc. has announced that it has negotiated an exclusive license from White Hall, Inc. for the micronized, amorphous silver ion technology to treat the highly contagious skin disease, Molluscum Contagiosum.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
Treatment with the novel neuroprotective agent NA-1 reduces the number of ischemic infarcts sustained by patients undergoing coiling of cerebral aneurysms, show the ENACT results.
› Verified 6 days ago
Joseph Philip Bernardini, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 994 West Sherman Ave, Vineland, NJ 08360 Phone: 856-696-0900 Fax: 856-692-4769 | |
Dr. Jason Paul Mora, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 994 W Sherman Ave, Vineland, NJ 08360 Phone: 609-267-9400 | |
Dr. Rahul V Shah, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 352 S Delsea Dr Ste C, Vineland, NJ 08360 Phone: 856-690-1616 | |
Elizabeth Ford, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-641-8000 | |
Dr. John David Jennings, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 994 W Sherman Ave, Vineland, NJ 08360 Phone: 609-267-9400 | |
Dr. Robert Paul Falconiero, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 352 S Delsea Dr Unit C, Vineland, NJ 08360 Phone: 856-690-1616 Fax: 856-896-6107 |